Apnimed, Inc., a late stage clinical pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep-related ...

The FDA's acceptance of the NDA for AD109 marks a pivotal clinical milestone toward introducing the first oral pharmacotherapy designed to target the neuromuscular causes of obstructive sleep apnea.

A Spanish trial finds positional therapy improves positional sleep apnea, is better tolerated than CPAP, and maintains benefits in many patients after treatment ends.

Spread the love“`html Sleep apnea is a serious health condition that disrupts your nightly rest, impacting your overall ...

Klar Yaggi was first drawn to sleep medicine for the mystery. “It’s still a very young field with a lot of interesting questions that remain to be asked and answered,” said Yaggi, professor of ...

Roughly one billion people worldwide are estimated to live with obstructive sleep apnea, and a large share of them don't know it. For the ones who do get diagno ...

Vitality Medical reports that Hawai‘i faces the largest gap between sleep therapy needs and access, with 45.4% of residents ...

Do you snore? Do you feel tired during the day? If the answer is yes, you may have sleep apnea. Obstructive sleep apnea ...

Millions of people sleep every night but never truly rest. Their breathing repeatedly stops and starts during sleep, often without them realizing it. This cond ...